Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

CRDFCRDF
Showing 3 of 14 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in CARDIFF ONCOLOGY INC

Qube Research & Technologies Ltd holds 125,550 shares of CRDF (CARDIFF ONCOLOGY INC), worth $163,215 as of 2026-Q2. This is a new position. CRDF represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$163,215

Current Shares

125,550

Total Value Change

+$63,771

Total Shares Change

+88,305

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
125,550
-
$163,2150.0%$1.30
31
2024-Q4
Exited
0
-100.0%
$00.0%$4.26
0
2024-Q3
Decreased
37,245
-8.4%
$99,4440.0%$2.77
0

Other major holders of CRDF: RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used